Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease
-
DelphX Announces Non-Brokered Unit Private Placement
-
Rock Tech Lithium Announces Offering of up to $7.5 Million
-
Millennium Silver Corp. Announces Termination of Simon Option Agreement
-
Sword Group: Availability of the H1 2025 Financial Report
-
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
-
Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development
-
Sword Group: H1 2025 Report of the Liquidity Agreement contracted with ODDO BHF
-
Dustin Sedgwick joins Intapp as Chief Marketing Officer
-
Kadestone Capital Corp. Reports Q2 2025 Financial Results
-
Governor Brad Little Visits Tamarack Resort to Review Fire Response and Resort Growth
-
San Francisco Bay University to Launch New Business Incubator, Innovate Bay
-
Colossus Resources Announces Debt Settlement and Non-Brokered Private Placement Financing
-
Seegnal Inc. Announces Completion of Qualifying Transaction
-
Dr. Colleen Cowdery Joins Washington Poison Center as Chief Medical Officer Strengthening Statewide Toxicology Expertise
-
Tornado Infrastructure Equipment Reports Second Quarter 2025 Results
-
Newsom's Energy Commission Freezes Price Gouging Penalty, Leaves Consumers Open to Gasoline Price Spikes, says Consumer Watchdog
-
Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB
-
Centrus Energy to Participate in Upcoming Investor Events
-
Northland Announces Reset Dividend Rate on Its Cumulative Rate Reset Preferred Shares, Series 1 & Series 2
-
SonicStrategy Announces Final OTCQB and DTC Eligibility Approval
-
Northland Announces Reset Dividend Rate on Its Cumulative Rate Reset Preferred Shares, Series 1 & Series 2
-
Organto Foods Closes $8.0 Million Private Placement Financing
-
Biomerica Reports Fiscal 2025 Year End Results
-
Corey Barss Named VP of Operations as FIELDBOSS Expands Leadership to Support Contractor Growth in HVAC and Elevator Markets
-
PicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
PicoCELA Inc. Issues Restricted Common Shares to MCC and You Planning
-
37 Capital Closes First Tranche of Private Placement
-
Enduro Metals Announces Extension to Deadline to Complete Second Tranche of Financing
-
Adelayde Exploration Inc. Provides Corporate Update
-
Turnium Technology Group Reports 72.5% YoY Revenue Growth for Fiscal Q3 2025
-
Ciscom Corp. Announces Business and Corporate Updates
-
Newcore Gold Announces Annual Grant of Equity Incentive Awards
-
Helium Evolution Closes $8.3 Million Convertible Note and Announces Q2-2025 Results
-
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
-
MAC Copper Limited Announces MAC Shareholders Vote in Favour of Scheme With Harmony
-
Funko Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Patagonia Gold Quarter 2, 2025 Financial Results
-
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
-
Interim Report January – June 2025
-
RSLV Aesthetics Leading the Way in Aesthetics Weight Loss and Wellness Services in Jacksonville FL
-
Pulsar Helium Announces Closing of Fundraise
-
Scheffler Bausanierung Launches in Frankfurt with a Fresh Approach to Renovation & Construction
-
AS Silvano Fashion Group Consolidated Interim Financial Report for Q2 and 6m of 2025 (unaudited
-
Tilson Technology Management Selects ITG Communications Offer as Winning Bid in Auction
-
Scheffler Bausanierung Launches in Frankfurt with a Fresh Approach to Renovation & Construction
-
Mine Permit Received Approving Mount Polley’s Life of Mine Plan
-
Alliance Recovery Expands in Orange County, California, Improving Access to Affordable Addiction Treatment
-
Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company’s Financial Position
-
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
